| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Departments of Medicine and Immunology, Division of Rheumatology, University of Colorado Health Sciences Center, Denver, CO 80262; and
Simmons Arthritis Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75235
Complement receptor 2 (CD21, CR2) is a B cell receptor for complement degradation products bound to Ag or immune complexes. The role of CD21 in mediating Ag presentation of soluble immune complexes by resting B cells was studied. Complement-coated immune complexes were formed by the incubation of influenza virus with serum from immune donors. These complexes bound to peripheral blood B cells in a complement-dependent manner. The binding required CD21 or, to a lesser extent, complement receptor 1 (CR1, CD35). B cells pulsed with immune complexes containing complement elicited a response from a panel of influenza-specific T cell clones, while those pulsed with immune complexes formed in the absence of complement did not. The expression of the early activation marker CD69 and the costimulatory molecule CD86 were not induced by CD21 ligation alone, suggesting that CD21-mediated Ag presentation occurs independently of B cell activation. Up-regulation of these markers required exposure to T cell factors elicited by the recognition of Ag derived from complement-containing immune complexes. These findings suggest that binding of Ag to CD21 enables Ag-nonspecific B cells to participate in the activation of Ag-specific T cells in a process that occurs independently of well-characterized B cell activation events.
This article has been cited by other articles:
|
|
 |
|
  A. C. Jacobson, K. M. Roundy, J. J. Weis, and J. H. Weis Regulation of Murine Splenic B Cell CR3 Expression by Complement Component 3 J. Immunol., September 15, 2009; 183(6): 3963 - 3970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Asokan, J. Hua, K. A. Young, H. J. Gould, J. P. Hannan, D. M. Kraus, G. Szakonyi, G. J. Grundy, X. S. Chen, M. K. Crow, et al. Characterization of Human Complement Receptor Type 2 (CR2/CD21) as a Receptor for IFN-{alpha}: A Potential Role in Systemic Lupus Erythematosus J. Immunol., July 1, 2006; 177(1): 383 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Brown, D. V. Barrault, A. Phythian-Adams, and A. M. Knight Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells Int. Immunol., January 1, 2006; 18(1): 69 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sturfelt and L. Truedsson Complement and its breakdown products in SLE Rheumatology, October 1, 2005; 44(10): 1227 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, D. Perry, S. A. Boackle, E. S. Sobel, H. Molina, B. P. Croker, and L. Morel Several Genes Contribute to the Production of Autoreactive B and T Cells in the Murine Lupus Susceptibility Locus Sle1c J. Immunol., July 15, 2005; 175(2): 1080 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Barrault and A. M. Knight Distinct Sequences in the Cytoplasmic Domain of Complement Receptor 2 Are Involved in Antigen Internalization and Presentation J. Immunol., March 15, 2004; 172(6): 3509 - 3517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Lindorfer, H. B. Jinivizian, P. L. Foley, A. D. Kennedy, M. D. Solga, and R. P. Taylor B Cell Complement Receptor 2 Transfer Reaction J. Immunol., April 1, 2003; 170(7): 3671 - 3678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Nielsen and R. G. Q. Leslie Complement's participation in acquired immunity J. Leukoc. Biol., August 1, 2002; 72(2): 249 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shirota, K. Sano, N. Hirasawa, T. Terui, K. Ohuchi, T. Hattori, and G. Tamura B Cells Capturing Antigen Conjugated with CpG Oligodeoxynucleotides Induce Th1 Cells by Elaborating IL-12 J. Immunol., July 15, 2002; 169(2): 787 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Prechl, D. C. Baiu, A. Horvath, and A. Erdei Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen Int. Immunol., March 1, 2002; 14(3): 241 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cherukuri, P. C. Cheng, and S. K. Pierce The Role of the CD19/CD21 Complex in B Cell Processing and Presentation of Complement-Tagged Antigens J. Immunol., July 1, 2001; 167(1): 163 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Applequist, J. Dahlstrom, N. Jiang, H. Molina, and B. Heyman Antibody Production in Mice Deficient for Complement Receptors 1 and 2 Can Be Induced by IgG/Ag and IgE/Ag, But Not IgM/Ag Complexes J. Immunol., September 1, 2000; 165(5): 2398 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Merica, A. Khoruts, K. A. Pape, R. L. Reinhardt, and M. K. Jenkins Antigen-Experienced CD4 T Cells Display a Reduced Capacity for Clonal Expansion In Vivo That Is Imposed by Factors Present in the Immune Host J. Immunol., May 1, 2000; 164(9): 4551 - 4557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Watanabe, G. Garnier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B J. Immunol., January 15, 2000; 164(2): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
